FHA
KERX

First Horizon Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

First Horizon Advisors’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-690
Closed -$2K – 1436
2015
Q3 		$2K Hold
690
– – ﹤0.01% 1310
2015
Q2 		$6K Buy
690
+34
+5% +$365 ﹤0.01% 1181
2015
Q1 		$8K Hold
656
– – ﹤0.01% 1121
2014
Q4 		$9K Hold
656
– – ﹤0.01% 1086
2014
Q3 		$9K Buy
656
+32
+5% +$490 ﹤0.01% 1114
2014
Q2 		$9K Hold
624
– – ﹤0.01% 1081
2014
Q1 		$9K Hold
624
– – ﹤0.01% 1002
2013
Q4 		$9K Buy
+624
New +$7.45K ﹤0.01% 971

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Horizon Advisors's KERX Position: Q4 2015 in Review

First Horizon Advisors sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2015, closing a stake of 690 shares — an estimated $2K sold.

First Horizon Advisors first reported a position in KERX in Q4 2013 and held it in 8 quarters. The position peaked at $9K in Q4 2014. 128 funds tracked by Wall St. Rank hold KERX as of Q4 2015.

  • First Horizon Advisors reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • First Horizon Advisors sold 690 Keryx Biopharmaceuticals Inc shares in Q4 2015, an estimated $2K.
  • First Horizon Advisors first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 8 quarters.
  • First Horizon Advisors's Keryx Biopharmaceuticals Inc position peaked at $9K in Q4 2014.
  • 128 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2015.

Based on First Horizon Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.